Alessio Nahmad

Alessio Nahmad is a highly accomplished researcher with numerous scholarships, awards and co-inventor on patent applications. He is the first author of 3 high-impact publications and is committed to engineering multimodal cell therapies to enhance interactions with the immune system. He developed a novel immunotherapy platform for the treatment of escape-prone diseases, known as B cell engineering, and a co-founder a seed-stage biotech company that aims to bring his innovative works to life.